The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Lanreotide depot (LAN) for symptomatic control of carcinoid syndrome (CS) in neuroendocrine tumor (NET) patients previously responsive to octreotide (OCT): Subanalysis of patient-reported symptoms from the phase III elect study.
 
George A. Fisher
Stock and Other Ownership Interests - Seagen (I)
Honoraria - Merck, Genentech, Ipsen
Consulting or Advisory Role - Celgene; ipsen
Research Funding - Aduro Biotech (Inst); Bristol-Myers Squibb (Inst); EpicentRx (Inst); Forty seven (Inst); Genentech/Roche (Inst); Ipsen (Inst); Merck (Inst); Newlink Genetics (Inst); Pharmaceutical Research Associates (Inst); Polaris (Inst); Sun Pharma (Inst); XBiotech (Inst)
Travel, Accommodations, Expenses - Genentech/Roche; Merck
 
Rodney F. Pommier
Consulting or Advisory Role - Ipsen; Novartis
 
Edward M. Wolin
Honoraria - Ipsen; Novartis
Consulting or Advisory Role - Celgene; Ipsen; Novartis; Pfizer
Research Funding - Ipsen (Inst); Novartis (Inst)
 
Pamela L. Kunz
Stock and Other Ownership Interests - Guardant Health
Consulting or Advisory Role - Ipsen; Lexicon; Novartis
Research Funding - Advanced Accelerator Applications (Inst); Dicerna (Inst); Esanex (Inst); Genentech/Roche (Inst); Ipsen (Inst); Lexicon (Inst); Merck (Inst); Oxigene (Inst)
 
Nilani Liyanage
Employment - Ipsen
 
Susan W. Pitman Lowenthal
Employment - Ipsen
 
Beloo Mirakhur
Employment - Ipsen
 
Montaser F. Shaheen
No Relationships to Disclose
 
Aaron Vinik
Consulting or Advisory Role - Alnylam; Astellas Pharma; Hydra Biosciences; ION Pharma; Ipsen; Merck; Pfizer
Speakers' Bureau - Merck
Research Funding - Matrix Biomed (Inst); Nestle health science (Inst); Novo Nordisk (Inst); VeroScience (Inst); ViroMed (Inst)